Philip Tsai

Teknisk/Vetenskaplig/F&U Direktör på IMMUNOME, INC.

Förmögenhet: 2 M $ per 2026-06-30

58 år

Health Technology

Consumer Services

Profil

Philip Tsai is Chief Technical Officer at Immunome, Inc. since 2024.
Dr. Tsai was Senior Vice President-Technical Development at Seagen, Inc. from 2021 to 2024.
Education includes graduate and doctorate degrees from California Institute of Technology and an undergraduate degree from the University of Illinois At Urbana–Champaign.

Kända innehav i offentliga företag

Företag	Datum	Antal aktier	Värdering	Värderingsdatum
IMMUNOME, INC. 0,07 %	2026-07-23	81 550 ( 0,07 % )	2 M $	2026-06-30

Aktiva positioner av Philip Tsai

Företag	Position	Start
IMMUNOME, INC.	Teknisk/Vetenskaplig/F&U Direktör	2024-06-27

Alla aktiva positioner av Philip Tsai

Tidigare kända positioner av Philip Tsai

Företag	Position	Slut
SEAGEN INC.	Teknisk/Vetenskaplig/F&U Direktör	2024-04-01

Se detaljerna i Philip Tsais erfarenhet

Philip Tsais utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Philip Tsais erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	4
Seagen, Inc. Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases	Health Technology
Immunome, Inc. Immunome, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company which discovers, develops and commercializes antibody therapeutics	Health Technology
California Institute of Technology California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Illinois At Urbana–Champaign University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services